Novo Nordisk (NVO) stock is falling Friday morning after the pharmaceutical giant shared that additional weight loss tied to higher doses of its oral drug was "limited" in its latest trial results.

Dr. Patricia Brubaker and Dr. Pieter Cohen are the speakers at this year’s Trottier Public Science Symposium, Monday at 7 p.m. at McGill University’s Leacock Building, Room 132. Admission is free, but ...

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

Three doctors have expressed concerns to Newsweek about weight loss drugs for children, with research suggesting an initial reluctance to prescribe them.

FedEx cut its outlook after posting lower quarterly profit and revenue. Its stock fell 13%; shares of rival UPS also fell. Ford and General Motors fell after Mercedes-Benz trimmed its forecasts and ...

Stock futures edged lower as the dust settled after Thursday's rally, and bond yields traded just shy of two week highs. Investors will see option contracts tied to more than $5 trillion in tradeable ...

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...

It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Hims & Hers Health will offer compounded GLP-1 weight-loss medications for as low as $99 per month to eligible U.S. military ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...